Target Name: NCOR2
NCBI ID: G9612
Review Report on NCOR2 Target / Biomarker Content of Review Report on NCOR2 Target / Biomarker
NCOR2
Other Name(s): TRAC1 | TRAC | Nuclear receptor corepressor 2, transcript variant 1 | nuclear receptor corepressor 2 | Silencing mediator for retinoid and thyroid hormone receptors | TRAC-1 | T3 receptor-associating factor | SMRT | SMAP270 | CTG repeat protein 26 | Nuclear receptor corepressor 2 (isoform 1) | Nuclear receptor corepressor 2 (isoform 2) | Silencing mediator of retinoic acid and thyroid hormone receptor | N-CoR2 | SMRTE | thyroid-, retinoic-acid-receptor-associated corepressor | Nuclear receptor corepressor 2 | CTG26 | TNRC14 | Nuclear receptor corepressor 2, transcript variant 2 | silencing mediator for retinoid and thyroid hormone receptors | Thyroid-, retinoic-acid-receptor-associated corepressor | NCOR2 variant 2 | NCOR2 variant 1 | SMRTE-tau | NCOR2_HUMAN

NCOR2 (TRAC1) as a Drug Target and Biomarker: Implications for the Treatment of Chronic Pain

Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used to alleviate pain and inflammation in individuals with chronic pain conditions. However, the use of NSAIDs often results in side effects, such as stomach ulcers, bleeding, and kidney damage. The search for safer and more effective pain treatments has led to the development of alternative biomarkers and drug targets. One such target is the neurotransmitter TRAC1, which is a key regulator of pain signaling in the central nervous system. The present article will discuss NCOR2 (TRAC1) as a drug target and biomarker in the context of chronic pain management.

The TRAC1 Signaling Pathway

TRAC1 is a G protein-coupled receptor that is involved in the regulation of pain signaling. It is a seven-transmembrane protein that is expressed in various tissues, including the central nervous system, endocrine system, and peripheral tissues. TRAC1 signaling is involved in the regulation of pain perception, neuroinflammation, and neuroprotection.

The TRAC1 signaling pathway consists of several key components, including TRAC1 receptor, TRAC1 signaling complex, and TRAC1-targeted proteins. The TRAC1 receptor is a G protein-coupled receptor that consists of an extracellular domain, a transmembrane domain, and an intracellular domain. The TRAC1 signaling complex is a protein complex that consists of various components, including TRAC1 receptor, TRAC1 co-receptor, TRAC1 signaling kinases, and TRAC1-targeted proteins. The TRAC1-targeted proteins are involved in the regulation of pain signaling and neuroinflammation.

NCOR2 (TRAC1) as a Drug Target

NCOR2 is a non-coding RNA molecule that is similar to TRAC1 in terms of its structure and function. It is a splicing factor that is involved in the regulation of gene expression. NCOR2 has been shown to play a role in the regulation of pain signaling by TRAC1.

NCOR2 has been shown to interact with TRAC1, TRAC1 receptor, and TRAC1 signaling complex. This interaction between NCOR2 and TRAC1 has implications for the regulation of pain signaling.

NCOR2 has been shown to regulate the expression of pain-related genes, including heat shock factor-1 (HSF1), peroxisome proliferator-activated receptor (PPAR), and nuclear factor kappa B (NF-kappa-B). NCOR2 has also been shown to inhibit the activity of TRAC1 signaling complex, which may reduce the production of pain-related molecules.

NCOR2 may also play a role in the regulation of neuroinflammation. Chronic pain is often associated with neuroinflammation, which is a complex immune response to tissue damage. NCOR2 has been shown to regulate the production of pro-inflammatory cytokines, such as TNF-伪, IL-1尾, and IL-6, which are involved in the regulation of neuroinflammation.

NCOR2 may also be involved in the regulation of pain perception. Pain perception is a complex process that involves the interaction between pain signals and the central nervous system. NCOR2 has been shown to interact with TRAC1, which may influence the regulation of pain perception.

NCOR2 as a Biomarker

The TRAC1 signaling pathway is a potential drug target for the regulation of chronic pain. The inhibition of TRAC1 signaling complex by NCOR2 may provide a new approach to the treatment of chronic pain.

NCOR2 has also been shown to be a potential biomarker for the evaluation of chronic pain. The regulation of TRAC1 signaling complex by NCOR2 may be involved in the production of pain-related molecules, including inflammatory cytokines. The levels of these molecules can be used as biomarkers for the evaluation of chronic pain.

Conclusion

The TRAC1 signaling pathway is involved in the regulation of pain signaling in the central nervous system. NCOR2 (TRAC1) is a key component of this pathway and has implications for the regulation of pain signaling. The inhibition of NCOR2

Protein Name: Nuclear Receptor Corepressor 2

Functions: Transcriptional corepressor (PubMed:20812024). Mediates the transcriptional repression activity of some nuclear receptors by promoting chromatin condensation, thus preventing access of the basal transcription. Isoform 1 and isoform 4 have different affinities for different nuclear receptors. Involved in the regulation BCL6-dependent of the germinal center (GC) reactions, mainly through the control of the GC B-cells proliferation and survival. Recruited by ZBTB7A to the androgen response elements/ARE on target genes, negatively regulates androgen receptor signaling and androgen-induced cell proliferation (PubMed:20812024)

The "NCOR2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NCOR2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

NCR1 | NCR2 | NCR3 | NCR3LG1 | NCRUPAR | NCS1 | NCSTN | ND1 | ND2 | ND3 | ND4 | ND4L | ND5 | ND6 | NDC1 | NDC80 | NDC80 kinetochore complex | NDE1 | NDEL1 | NDFIP1 | NDFIP2 | NDN | NDNF | NDOR1 | NDP | NDRG1 | NDRG2 | NDRG3 | NDRG4 | NDST1 | NDST1-AS1 | NDST2 | NDST3 | NDST4 | NDUFA1 | NDUFA10 | NDUFA11 | NDUFA12 | NDUFA13 | NDUFA2 | NDUFA3 | NDUFA3P3 | NDUFA4 | NDUFA4L2 | NDUFA5 | NDUFA5P11 | NDUFA6 | NDUFA6-DT | NDUFA7 | NDUFA8 | NDUFA9 | NDUFAB1 | NDUFAF1 | NDUFAF2 | NDUFAF3 | NDUFAF4 | NDUFAF4P1 | NDUFAF5 | NDUFAF6 | NDUFAF7 | NDUFAF8 | NDUFB1 | NDUFB10 | NDUFB11 | NDUFB2 | NDUFB2-AS1 | NDUFB3 | NDUFB4 | NDUFB5 | NDUFB6 | NDUFB7 | NDUFB8 | NDUFB9 | NDUFC1 | NDUFC2 | NDUFC2-KCTD14 | NDUFS1 | NDUFS2 | NDUFS3 | NDUFS4 | NDUFS5 | NDUFS6 | NDUFS7 | NDUFS8 | NDUFV1 | NDUFV2 | NDUFV2P1 | NDUFV3 | NEAT1 | NEB | NEBL | NECAB1 | NECAB2 | NECAB3 | NECAP1 | NECAP2 | NECTIN1 | NECTIN2 | NECTIN3 | NECTIN3-AS1